4/A
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001234066-03-000007
President and CEO sold 3,000 shares at an average $3.17 ($9,507)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HARRIS ROBERT B President and CEO | 2003-07-17 | Sale | −900 | $3.20 | $2,880 | 53,221 | D |
| HARRIS ROBERT B President and CEO | 2003-07-17 | Sale | −1,200 | $3.16 | $3,792 | 52,021 | D |
| HARRIS ROBERT B President and CEO | 2003-07-17 | Sale | −900 | $3.15 | $2,835 | 51,121 | D |
| Open-market sales · 3,000 sh · avg $3.17 · $9,507 | |||||||
Loading xslF345X02/primary_doc.xml…